270 related articles for article (PubMed ID: 19499276)
21. SPARC mRNA expression as a prognostic marker for pancreatic adenocarcinoma patients.
Miyoshi K; Sato N; Ohuchida K; Mizumoto K; Tanaka M
Anticancer Res; 2010 Mar; 30(3):867-71. PubMed ID: 20393008
[TBL] [Abstract][Full Text] [Related]
22. [Expression of dihydropyrimidine dehydrogenase negatively correlated with the prognosis of pancreatic ductal adenocarcinoma].
Fang Y; Ji Y; Lou WH
Zhonghua Wai Ke Za Zhi; 2011 Apr; 49(4):330-4. PubMed ID: 21612699
[TBL] [Abstract][Full Text] [Related]
23. Low expression of junctional adhesion molecule A is associated with metastasis and poor survival in pancreatic cancer.
Fong D; Spizzo G; Mitterer M; Seeber A; Steurer M; Gastl G; Brosch I; Moser P
Ann Surg Oncol; 2012 Dec; 19(13):4330-6. PubMed ID: 22549289
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathological significance of galectin-3 expression in ductal adenocarcinoma of the pancreas.
Shimamura T; Sakamoto M; Ino Y; Shimada K; Kosuge T; Sato Y; Tanaka K; Sekihara H; Hirohashi S
Clin Cancer Res; 2002 Aug; 8(8):2570-5. PubMed ID: 12171885
[TBL] [Abstract][Full Text] [Related]
25. Peroxisome proliferator-activated receptor-gamma and retinoid X receptor-alpha expression in pancreatic ductal adenocarcinoma: association with clinicopathological parameters, tumor proliferative capacity, and patients' survival.
Giaginis C; Katsamangou E; Tsourouflis G; Zizi-Serbetzoglou D; Kouraklis G; Theocharis S
Med Sci Monit; 2009 May; 15(5):BR148-56. PubMed ID: 19396032
[TBL] [Abstract][Full Text] [Related]
26. L1 Cell adhesion molecule (L1CAM) expression at the cancer invasive front is a novel prognostic marker of pancreatic ductal adenocarcinoma.
Tsutsumi S; Morohashi S; Kudo Y; Akasaka H; Ogasawara H; Ono M; Takasugi K; Ishido K; Hakamada K; Kijima H
J Surg Oncol; 2011 Jun; 103(7):669-73. PubMed ID: 21360711
[TBL] [Abstract][Full Text] [Related]
27. Clinical significance of folate receptor β-expressing tumor-associated macrophages in pancreatic cancer.
Kurahara H; Takao S; Kuwahata T; Nagai T; Ding Q; Maeda K; Shinchi H; Mataki Y; Maemura K; Matsuyama T; Natsugoe S
Ann Surg Oncol; 2012 Jul; 19(7):2264-71. PubMed ID: 22350599
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathological correlations of nestin expression in surgically resectable pancreatic cancer including an analysis of perineural invasion.
Lenz J; Karasek P; Jarkovsky J; Muckova K; Dite P; Kala Z; Veselska R; Hermanova M
J Gastrointestin Liver Dis; 2011 Dec; 20(4):389-96. PubMed ID: 22187705
[TBL] [Abstract][Full Text] [Related]
29. Increased expression of MUC1 in advanced pancreatic cancer.
Hinoda Y; Ikematsu Y; Horinochi M; Sato S; Yamamoto K; Nakano T; Fukui M; Suehiro Y; Hamanaka Y; Nishikawa Y; Kida H; Waki S; Oka M; Imai K; Yonezawa S
J Gastroenterol; 2003; 38(12):1162-6. PubMed ID: 14714254
[TBL] [Abstract][Full Text] [Related]
30. High expression of interleukin-22 and its receptor predicts poor prognosis in pancreatic ductal adenocarcinoma.
Wen Z; Liao Q; Zhao J; Hu Y; You L; Lu Z; Jia C; Wei Y; Zhao Y
Ann Surg Oncol; 2014 Jan; 21(1):125-32. PubMed ID: 24132627
[TBL] [Abstract][Full Text] [Related]
31. [Clinicopathological significance of the expression of carbonic anhydrase I and II in human pancreatic cancer].
Sheng WW; Dong M; Zhou JP; Kong FM; Li YJ
Zhonghua Yi Xue Za Zhi; 2012 Dec; 92(48):3407-11. PubMed ID: 23327700
[TBL] [Abstract][Full Text] [Related]
32. Invasive intraductal papillary-mucinous neoplasm of the pancreas: comparison with pancreatic ductal adenocarcinoma.
Murakami Y; Uemura K; Sudo T; Hayashidani Y; Hashimoto Y; Nakashima A; Sueda T
J Surg Oncol; 2009 Jul; 100(1):13-8. PubMed ID: 19384908
[TBL] [Abstract][Full Text] [Related]
33. Comparative proteomic analysis for the detection of biomarkers in pancreatic ductal adenocarcinomas.
Qi T; Han J; Cui Y; Zong M; Liu X; Zhu B
J Clin Pathol; 2008 Jan; 61(1):49-58. PubMed ID: 17412869
[TBL] [Abstract][Full Text] [Related]
34. Survivin expression is a prognostic marker in pancreatic cancer patients.
Kami K; Doi R; Koizumi M; Toyoda E; Mori T; Ito D; Fujimoto K; Wada M; Miyatake S; Imamura M
Surgery; 2004 Aug; 136(2):443-8. PubMed ID: 15300213
[TBL] [Abstract][Full Text] [Related]
35. Synuclein-gamma is closely involved in perineural invasion and distant metastasis in mouse models and is a novel prognostic factor in pancreatic cancer.
Hibi T; Mori T; Fukuma M; Yamazaki K; Hashiguchi A; Yamada T; Tanabe M; Aiura K; Kawakami T; Ogiwara A; Kosuge T; Kitajima M; Kitagawa Y; Sakamoto M
Clin Cancer Res; 2009 Apr; 15(8):2864-71. PubMed ID: 19351749
[TBL] [Abstract][Full Text] [Related]
36. Chemokine receptor CCR7 expression correlates with lymph node metastasis in pancreatic cancer.
Nakata B; Fukunaga S; Noda E; Amano R; Yamada N; Hirakawa K
Oncology; 2008; 74(1-2):69-75. PubMed ID: 18544997
[TBL] [Abstract][Full Text] [Related]
37. Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma.
Van den Broeck A; Sergeant G; Ectors N; Van Steenbergen W; Aerts R; Topal B
Eur J Surg Oncol; 2009 Jun; 35(6):600-4. PubMed ID: 19131205
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of B2M and loss of ALK7 expression are associated with invasion, metastasis, and poor-prognosis of the pancreatic ductal adenocarcinoma.
Liu C; Yang Z; Li D; Liu Z; Miao X; Yang L; Zou Q; Yuan Y
Cancer Biomark; 2015; 15(6):735-43. PubMed ID: 26406402
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of thymidine phosphorylase expression for pancreatic cancer.
Hong SP; Shin SK; Bang S; Park SW; Chung JB; Lee WJ; Song SY
Hepatogastroenterology; 2009; 56(93):1178-82. PubMed ID: 19760965
[TBL] [Abstract][Full Text] [Related]
40. Preoperative serum CA19-9 and dissected peripancreatic tissue margin as determiners of long-term survival in pancreatic cancer.
Waraya M; Yamashita K; Katagiri H; Ishii K; Takahashi Y; Furuta K; Watanabe M
Ann Surg Oncol; 2009 May; 16(5):1231-40. PubMed ID: 19263172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
